phospho-VEGF receptor 2 (Tyr996)磷酸化血管内皮生长因子受体2抗体

本公司经销phospho-VEGF receptor 2 （Tyr996），磷酸化血管内皮生长因子受体2抗体，克隆类型为polyclonal，宿主来源是Rabbit，phospho-VEGF receptor 2 （Tyr996）磷酸化血管内皮生长因子受体2抗体可应用于WB、elisa、IP、IF、IHC等实验，欢迎垂询订购！

货号：BY-3470R
英文名称：Anti-phospho-VEGF receptor 2 （Tyr996）
中文名称：磷酸化血管内皮生长因子受体2抗体
其他名称：名CD309 antigen; Fetal liver kinase 1; FLK1; KDR; Kinase ｉnsert domain receptor; KRD1; Ly73; Protein tyrosine kinase receptor FLK1; Vascular endothelial growth factor receptor 2; VEGFR 2; VEGFR; VEGFR2.
抗体来源：Rabbit
克隆类型：polyclonal
蛋白分子量：predicted molecular weight: 26kDa
纯化方法：affinity purified by Protein A
交叉反应：hu
产品介绍：VEGF receptor 2 is a member of a receptor tyrosine kinase family whose activation plays an essential role in a large number of biological processes such as embryonic development, wound healing, cell proliferation, migration ａnd differentiation. Like other growth factor receptors, upon ligand binding VEGF receptor 2 dimerises ａnd is autophosphorylated on multiple tyrosine residues. These sites can be involved in the regulation of kinase activity or serve as binding sites for SH2 ａnd phosphotyrosine binding containing signalling proteins. Phosphorylation of Tyrosines 1054 ａnd 1059 in the activation loop is required for activation of VEGF receptor 2 ａnd its intrinsic tyrosine kinase activity. In case of HIV-1 infection, the interaction with extracellular viral Tat protein seems to enhance angiogenesis in Kaposi＇s sarcoma lesions.